Mereo BioPharma MREO
NASDAQ MREO
$0.28 -0.01 (-1.98%)
At close: Oct 23, 2026 · 4:00 PM EDT

Mereo BioPharma (MREO) Liabilities and Shareholders Equity (2017 - 2026)

Updated

Mereo BioPharma's Liabilities and Shareholders Equity came in at $34.71 million for Q2 2026, down 44.6% from $62.63 million a year earlier and down 14.5% from the prior quarter.

Analysis

Mereo BioPharma (MREO) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends

At the end of FY2025, Mereo BioPharma's Liabilities and Shareholders Equity was $45.92 million, down 39.9% from FY2024.

  • Liabilities and Shareholders Equity carries a three-year compound annual growth rate of -16.0% (FY2022 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $76.39 million in FY2024 (+14.9%), $66.5 million in FY2023 (-14.1%) and $77.41 million in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2017.
  • Year-over-year, Liabilities and Shareholders Equity has declined for five consecutive quarters, with an average decline of 23.2% over the last seven quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2025 (growth of 22.1%), and the weakest in Q2 2026 (a decline of 44.6%).
  • Business Quant data shows MREO's Liabilities and Shareholders Equity at $40.61 million (Q1 2026), $45.92 million (Q4 2025) and $53.6 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 142.28 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 197.43 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 135.12 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 129.80 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 115.83 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 95.64 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 49.36 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 201.13 Bn
10 Mereo BioPharma 44.55 Mn -105.36 Mn - 34.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 34.71 Mn
Mar 31, 2026 40.61 Mn
Dec 31, 2025 45.92 Mn
Sep 30, 2025 53.60 Mn
Jun 30, 2025 62.63 Mn
Mar 31, 2025 68.32 Mn
Dec 31, 2024 76.39 Mn
Sep 30, 2024 88.75 Mn
Jun 30, 2024 96.13 Mn
Mar 31, 2024 55.94 Mn
Dec 31, 2023 66.50 Mn
Dec 31, 2022 77.41 Mn
Jun 30, 2020 135.15 Mn
Dec 31, 2019 113.36 Mn
Jun 30, 2019 135.83 Mn
Dec 31, 2018 85.40 Mn
Dec 31, 2017 129.48 Mn
API Access

Mereo BioPharma Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=MREO&period=max&api_key=YOUR_API_KEY